We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.78B
AUM Growth
-$2.15B
Cap. Flow
-$2.29B
Cap. Flow %
-60.64%
Top 10 Hldgs %
32.15%
Holding
6,174
New
508
Increased
1,418
Reduced
3,468
Closed
480

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$269M
2
SMCI icon
Super Micro Computer
SMCI
+$220M
3
SPXL icon
Direxion Daily S&P 500 Bull 3x ETF
SPXL
+$68M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$61M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.5M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$215M
2
MSFT icon
Microsoft
MSFT
+$203M
3
NVDA icon
NVIDIA
NVDA
+$156M
4
AMZN icon
Amazon
AMZN
+$119M
5
META icon
Meta Platforms (Facebook)
META
+$97.9M

Sector Composition

Rank Sector Weight
1 Technology 21.67%
2 Financials 9.06%
3 Consumer Discretionary 7.38%
4 Healthcare 7.08%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SSP icon
3551
E.W. Scripps
SSP
$312M
$13K ﹤0.01%
5,773
-8,007
-58% -$20.5K
PSO icon
3552
Pearson
PSO
$9.73B
$13K ﹤0.01%
955
-1,110
-54% -$14.9K
TFPM icon
3553
Triple Flag Precious Metals
TFPM
$6.48B
$12.9K ﹤0.01%
+800
New +$12.8K
MAYS icon
3554
J.W. Mays
MAYS
$12.9K ﹤0.01%
296
-201
-40% -$8.83K
UGL icon
3555
ProShares Ultra Gold
UGL
$807M
$12.8K ﹤0.01%
536
-520
-49% -$11.2K
FBLG icon
3556
FibroBiologics
FBLG
$7.06M
$12.8K ﹤0.01%
+208
New +$13.8K
SRTA
3557
Strata Critical Medical Inc
SRTA
$524M
$12.8K ﹤0.01%
4,361
-3,873
-47% -$12.3K
OILD icon
3558
MicroSectors Oil & Gas Exp. & Prod. -3x Inverse Leveraged ETN
OILD
$31.2M
$12.8K ﹤0.01%
74
-39
-35% -$6.44K
DOMO icon
3559
Domo
DOMO
$184M
$12.8K ﹤0.01%
1,706
-1,911
-53% -$14.6K
GPRO icon
3560
GoPro
GPRO
$110M
$12.8K ﹤0.01%
9,420
-39,245
-81% -$54K
LXEO icon
3561
Lexeo Therapeutics
LXEO
$391M
$12.8K ﹤0.01%
1,417
-158
-10% -$1.88K
ZURA icon
3562
Zura Bio
ZURA
$526M
$12.8K ﹤0.01%
3,154
-4,067
-56% -$15.2K
BV icon
3563
BrightView Holdings
BV
$1.09B
$12.8K ﹤0.01%
813
-15,178
-95% -$220K
MVBF icon
3564
MVB Financial
MVBF
$401M
$12.8K ﹤0.01%
660
-3,639
-85% -$75.4K
STRO icon
3565
Sutro Biopharma
STRO
$352M
$12.7K ﹤0.01%
368
-820
-69% -$32.1K
SNOA icon
3566
Sonoma Pharmaceuticals
SNOA
$6.22M
$12.7K ﹤0.01%
4,141
+3,728
+903% +$19K
UTMD icon
3567
Utah Medical Products
UTMD
$229M
$12.7K ﹤0.01%
190
-338
-64% -$22.9K
CDXS icon
3568
Codexis
CDXS
$169M
$12.7K ﹤0.01%
4,115
-3,133
-43% -$9.69K
VUG icon
3569
Vanguard Morningstar Growth ETF
VUG
$230B
$12.7K ﹤0.01%
198
-72
-27% -$4.46K
FF icon
3570
Future Fuel
FF
$247M
$12.7K ﹤0.01%
2,200
-2,476
-53% -$13.8K
XPRO icon
3571
Expro Ltd
XPRO
$2.13B
$12.6K ﹤0.01%
735
-30,443
-98% -$619K
PARAA
3572
DELISTED
Paramount Global Class A
PARAA
$12.6K ﹤0.01%
577
-356
-38% -$7.87K
BBAR icon
3573
BBVA Argentina
BBAR
$3.17B
$12.6K ﹤0.01%
1,214
+410
+51% +$4.02K
KXIN icon
3574
Kaixin Holdings
KXIN
$8.47M
$12.6K ﹤0.01%
+2
New +$5.3K
BAR icon
3575
GraniteShares Gold Shares
BAR
$1.48B
$12.6K ﹤0.01%
484
-14,316
-97% -$350K
141 142
143
144 145

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2024 Portfolio in Review

As of Q3 2024, Tower Research Capital (TRC) held 6,174 positions worth $3.78B, down 36% from $5.92B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.29B in Q3 2024, closing 480 positions and reducing 3,468 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $9.26M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares US Technology ETF worth $6.83M.

  • Tower Research Capital (TRC)'s largest Q3 2024 buy was iShares US Technology ETF: 45,025 shares worth $6.83M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q3 2024, an estimated $269M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2024 reduction was Apple, cutting an estimated $215M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2024, selling an estimated $9.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.78B portfolio in Q3 2024.
  • Tower Research Capital (TRC) opened 508 new positions and closed 480 in Q3 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $3.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2024, filed 14 Nov 2024.